Mabwell News

Maiwei Biotech\'s announcement on holding the 2024 semi-annual and third quarter results briefing

Nov 21 00:00

Maiwei Biotech: Opinions of Haitong Securities Co., Ltd. on the matter of changing some special accounts for fund-raising and re-signing the quadripartite supervisory agreement

Oct 31 00:00

Maiwei Biotech: Miwei Biotech\'s announcement on changing some special fund-raising accounts and re-signing the quadripartite supervisory agreement

Oct 31 00:00

Maiwei Biotech: Announcement of Resolutions of the 13th Meeting of the 2nd Supervisory Board of Maiwei Biotech

Oct 31 00:00

Announcement of Resolutions of the 13th Meeting of the 2nd Supervisory Board of Maiwei Biotech

Oct 31 00:00

Maiwei Biotech Investor Relations Activity Record List (2024/09/01)

Sep 30 15:54

Haitong Securities Co., Ltd.\'s 2024 semi-annual follow-up report on the continuous supervision of Maiwei (Shanghai) Biotechnology Co., Ltd.

Sep 10 00:00

Announcement of Resolutions of the 12th Meeting of the 2nd Supervisory Board of Maiwei Biotech

Aug 31 00:00

Maiwei Biotech\'s special report on the storage and actual use of funds raised in the 2024 semi-year

Aug 31 00:00

Mabwell: Meiwei Biology voluntarily discloses the announcement of the Phase III clinical study of 9MW2821 combined with PD-1 monoclonal antibody for first-line treatment of urinary tract urothelial carcinoma, which has obtained the approval of the CDE.

Aug 26 00:00

Announcement of Maiwei Bio's increase in credit and financing amount applications to financial institutions for the 2024 fiscal year.

Aug 2 00:00

Announcement of resolutions of the 11th meeting of the second session of the supervisory board of Maiwei Biology.

Aug 2 00:00

Maiwei Biological Investor Relations Activity Record (July 02, 2024)

Aug 1 09:35

Maiwei Biology Investor Relations Activity Record Form (July 01, 2024)

Jul 22 09:30

Record of Investor Relations Activities for Maiwei Biology (June 01, 2024)

Jul 1 10:35

Announcement of Maiwei Biology on the convening of the 2023 annual and first quarter of 2024 earnings briefing.

Jun 15 00:00

Maiwei Biotech Investor Relations Activity Record List (2024/05/01)

May 31 17:13

Announcement of Resolutions of the 10th Meeting of the 2nd Supervisory Board of Maiwei Biotech

May 24 00:00

Haitong Securities Co., Ltd.'s inspection opinion on the termination and re-provision of guarantees for wholly-owned subsidiaries by Maiwei (Shanghai) Biotechnology Co., Ltd. and its wholly-owned subsidiaries

May 24 00:00

Maiwei Biotech Independent Director Candidate Statement and Commitment (Qin Zhengyu)

May 24 00:00